Find clinical trials for lung cancer. Search for lung cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 1,810
Active & ResponsiveNew
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Fairfax VA
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: Grand Rapids MI, Irving TX, San Antonio TX,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia
for
Pulmonary Aspiration
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT06654219
Recruiting
Active & ResponsiveNew
Rutgers University Study of the Genetics of Pulmonary Hypertension
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT07217522
Recruiting
Active & ResponsiveNew
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
for
Breast Neoplasms, Lung Neoplasms
Location: Providence RI
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT06974604
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
for
Viral Pneumonia
Location: Idaho Falls ID, Anderson SC, Dallas TX
Sponsor: Synairgen Research Ltd.
Sex: All
Age: 18+
Code: NCT06999603
Phase2, Recruiting
Active & ResponsiveNew
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
for
Respiratory Syncytial Virus Infections
Location: St Louis MO, Vancouver
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07092865
Phase2, Recruiting
Active & ResponsiveNew
Systems Biological Analysis of Immune Responses to RSV Vaccine
for
Respiratory Syncytial Virus (RSV)
Location: Decatur GA
Sponsor: Emory University
Sex: All
Age: 60+
Code: NCT07185399
Recruiting
Active & ResponsiveNew
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
for
Tobacco Dependence
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 50+
Code: NCT07220356
Recruiting
Active & ResponsiveNew
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy